Volume 10, Supplement 1 (Mar 2019)
Volume 10, Supplement 1 (Mar 2019)
Immuno-Oncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events
This supplement, certified for CME/CE/CPE credit, is jointly provided by:



Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care
March 17, 2019
PD-1/PD-L1 Inhibitors for Non–Small Cell Lung Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
March 17, 2019
Checkpoint Inhibitor Immunotherapy for Head and Neck Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
March 17, 2019
Immune-Related Adverse Events From Immunotherapy: Incorporating Care Step Pathways to Improve Management Across Tumor Types
March 17, 2019
Advertisement
Current Issue
Vol 17
No 3
May/Jun 2026
AI in Oncology Opportunity and Accountability
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, TCTCN, FAAN, FAPO
May 13, 2026
The Impact of Physical Activity Levels on Sexual Function in Breast Cancer Survivors An Integrative Review
Mary Sou, MSN, APRN, FNP-C, Ashley Martinez, DNP, APRN, FNP-BC, AOCNP®, CBCN, CPHQ, NEA-BC, NPD-BC, Joyce Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANP, FAAN Et al.
May 13, 2026
Addressing Tamoxifen-Associated Weight Gain Lifestyle and Pharmacotherapy Options
Latonya Fore-Williams, DNP, APRN, NP-C, CSOWM, CBN, CCM, Michele Distler, DNP, RN, CNE
May 13, 2026